Frontlight ResearchEarly access
Trial site
Rutgers cancer Institute of NJ
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Acute lymphoblastic leukaemia1 trial
- Childhood cancers1 trial
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 23 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Recruiting2 trials
- Lead sponsor
- Incyte Corporation3 trials
- Acrivon Therapeutics1 trial
- Eisai Inc.1 trial
- Novartis Pharmaceuticals1 trial
Running trials
Recruiting
Active, not recruiting
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Endometrial cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026